Chagas Disease (American Trypanosomiasis) Pipeline Review, H1 2016 - 10 Companies & Drug Profiles - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Chagas Disease (American Trypanosomiasis), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chagas Disease (American Trypanosomiasis) and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Chagas Disease (American Trypanosomiasis) Overview
  3. Therapeutics Development
  4. Pipeline Products for Chagas Disease (American Trypanosomiasis) - Overview
  5. Pipeline Products for Chagas Disease (American Trypanosomiasis) - Comparative Analysis
  6. Chagas Disease (American Trypanosomiasis) - Therapeutics under Development by Companies
  7. Chagas Disease (American Trypanosomiasis) - Therapeutics under Investigation by Universities/Institutes
  8. Chagas Disease (American Trypanosomiasis) Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Chagas Disease (American Trypanosomiasis) - Products under Development by Companies
  13. Chagas Disease (American Trypanosomiasis) - Products under Investigation by Universities/Institutes
  14. Chagas Disease (American Trypanosomiasis) - Companies Involved in Therapeutics Development
  • Anacor Pharmaceuticals, Inc.
  • Bayer AG
  • Eisai Co., Ltd.
  • GlaxoSmithKline Plc
  • Grupo Praxis Pharmaceutical SA
  • KaloBios Pharmaceuticals, Inc.
  • Merck & Co., Inc.
  • Panacela Labs, Inc.
  • Sanofi
  • SEEK Group

For more information visit http://www.researchandmarkets.com/research/jmlh6z/chagas_disease

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases Drugs